We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BiOracle Gets License to Appendicitis Test

By HospiMedica staff writers
Posted on 16 Apr 2004
A new diagnostic test for acute appendicitis has been licensed to BiOracle, Ltd. (Congleton, UK) by DMI BioSciences, Inc. (Englewood, CO, USA).

BiOracle was granted exclusive worldwide rights to develop and commercialize DMI's patented technology. DMI will receive milestone payments and royalties on sales.

Even though appendicitis is the most common surgical emergency requiring an operation, early diagnosis relies mainly on a physical examination and signs and symptoms that may be misleading. The new point-of-care test, called Appytest, will give doctors a rapid, noninvasive assay easy to administer that has high diagnostic specificity and may reduce unnecessary hospitalizations and surgeries. No rapid diagnostic biomarker currently has high diagnostic specificity for acute appendicitis, states DMI.

"BiOracle has a very experienced team rapidly building a portfolio of preventive care products for global markets,” said Bruce Miller, president and CEO of DMI. "We are very pleased that BiOracle is commercializing a test we believe will significantly improve patient care while reducing healthcare costs.”

DMI Biosciences is a biopharmaceutical company that discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. The company focuses on immunologic, vascular and central nervous system diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer's disease, asthma, and cancer.




Related Links:
DMI
BiOracle

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
FLU/RSV Test
Humasis FLU/RSV Combo
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests